Bioequivalence, Food Effect, and Steady‐State Assessment of Dapagliflozin/Metformin Extended‐release Fixed‐dose Combination Tablets Relative to Single‐component Dapagliflozin and Metformin Extended‐release Tablets in Healthy Subjects-Reference-Cited by-同舟云学术

Bioequivalence, Food Effect, and Steady‐State Assessment of Dapagliflozin/Metformin Extended‐release Fixed‐dose Combination Tablets Relative to Single‐component Dapagliflozin and Metformin Extended‐release Tablets in Healthy Subjects

Published:2015-07 Issue:7 Volume:37 Page:1517-1528
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Chang Ming,Liu Xiaoni,Cui Dapeng,Liang Dan,LaCreta Frank,Griffen Steven C.,Lubin Susan,Quamina‐Edghill Donette,Boulton David W.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference17 articles.

1. Glucophage [prescribing information]. Princeton, NJ: Bristol-Myers Squibb Company; 2009.

2. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetologia,2012

3. Dapagliflozin: more than just another oral glucose-lowering agent?;Katsiki;Expert Opin Investig Drugs,2010

4. Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes;Meng;J Med Chem,2008

5. Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes;List;Diabetes Care,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional Comparison;Clinical Therapeutics;2023-08

2. A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects;Drug Design, Development and Therapy;2023-04

3. Fed and fasted bioequivalence assessment of two formulations of extended-release fixed-dose combination dapagliflozin/metformin (10/1,000 mg) tablets in healthy subjects;Translational and Clinical Pharmacology;2023

4. Metformin-based single pill drug combinations for type 2 diabetes in primary care England: A time trend analysis;Primary Care Diabetes;2022-04

5. Validation of a novel UPLC-MS/MS method for estimation of metformin and empagliflozin simultaneously in human plasma using freezing lipid precipitation approach and its application to pharmacokinetic study;Journal of Pharmaceutical and Biomedical Analysis;2021-06